Evidence map›Paper›PMID 29632513›Full record

ArticleFrontiers in neurology2018

Risky Decision Making in Juvenile Myoclonic Epilepsy.

Iris Unterberger, Laura Zamarian, Manuela Prieschl, Melanie Bergmann, Gerald Walser, Gerhard Luef, Andrija Javor, Gerhard Ransmayr, Margarete Delazer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Iris UnterbergerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Laura ZamarianDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Manuela PrieschlDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Melanie BergmannDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Gerald WalserDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Gerhard LuefDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Andrija JavorDepartment of Neurology 2, Kepler University Hospital, Linz, Austria.
Gerhard RansmayrDepartment of Neurology 2, Kepler University Hospital, Linz, Austria.
Margarete DelazerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Universität Innsbruck · ATKepler Universitätsklinikum · ATInnsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is not known whether patients with juvenile myoclonic epilepsy (JME) differ from healthy people in decision making under risk, i.e., when the decision-making context offers explicit information about options, probabilities, and consequences already from the beginning. In this study, we adopted the Game of Dice Task-Double to investigate decision making under risk in a group of 36 patients with JME (mean age 25.25/SD 5.29 years) and a group of 38 healthy controls (mean age 26.03/SD 4.84 years). Participants also underwent a comprehensive neuropsychological assessment focused on frontal executive functions. Significant group differences were found in tests of psychomotor speed and divided attention, with the patients scoring lower than the controls. Importantly, patients made risky decisions more frequently than controls. In the patient group, poor decision making was associated with poor executive control, poor response inhibition, and a short interval since the last seizure episode. Executive control and response inhibition could predict 42% of variance in the frequency of risky decisions. This study indicates that patients with JME with poorer executive functions are more likely to make risky decisions than healthy controls. Decision making under risk is of major importance in every-day life, especially with regard to treatment decisions and adherence to long-term medical therapy. Since even a single disadvantageous decision may have long-lasting consequences, this finding is of high relevance.

Indexed as

cognitionexecutive functionsgamblingjuvenile myoclonic epilepsyneuropsychologyrisk-taking

Identifiers

PMID29632513
PMCPMC5879545
OpenAlexW2789439988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.